| Business Summary | | North
American
Scientific
Inc.
designs,
develops
and
produces
radioisotopic
products,
including
brachytherapy
seeds
and
radiopharmaceuticals,
for
the
treatment
and
diagnosis
of
disease.
The
Company
has
applied
its
expertise
in
radioisotopes
to
develop
and
market
products
for
medical,
environmental,
research
and
industrial
applications.
The
Company's
first
two
therapeutic
products
are
iodine-based
and
palladium-based
implantable
brachytherapy
seeds
for
the
treatment
of
prostate
cancer.
These
products
are
marketed
under
the
trademarks
IoGold
and
PdGold.
The
Company
is
also
testing
Apomate,
an
in
vivo
nuclear
medicine
imaging
agent
that
targets
cells
undergoing
apoptosis
or
necrosis,
two
forms
of
cell
death. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | North
American
Scientific
manufactures
and
markets
a
line
of
low-level
radiation
sources
and
reference
standards
for
medical,
scientific
and
industrial
uses,
including
the
treatment
of
cancer
and
other
diseases
and
the
calibration
of
equipment.
For
the
six
months
ended
4/30/01,
net
sales
rose
11%
to
$9.4
million.
Net
loss
totaled
$246
thousand
vs.
an
income
of
$2.6
million.
Results
reflect
sales
generated
by
the
brachytherapy
and
non-therapeutic
lines,
offset
by
increased
R&D
expenses. Recent Earnings Announcement For
the
3
months
ended
07/31/2001,
revenues
were
4,851;
after
tax
earnings
were
-1,832. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Irwin Gruverman, 67 Chairman | -- | -- | L. Cutrer, 45 Pres,
CEO, Director | $390K | -- | Alan Edrick, 32 CFO | 238K | $265K | Dollar amounts are as of 31-Oct-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|